The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Circulating microRNA associated to different stages of liver steatosis in Prader-Willi syndrome and non-syndromic obesity

Pratama MY, Pascut D, Tamini S, Minocci A, Tiribelli C, Grugni G, Sartorio A

J Clin Med. 2020 Apr 14;9(4):1123.doi: 10.3390/jcm9041123.

2020

Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: A new pathway of neurotoxicity

Rauti R, Qaisiya M, Tiribelli C, Ballerini L, Bellarosa C

Arch Toxicol. 2020 Mar;94(3):845-855. doi: 10.1007/s00204-020-02659-9. Epub 2020 Mar 3.

2020

The importance of transaminases flare in liver elastography: Characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis

Giuffrè M, Fouraki S, Comar M, Masutti F, Crocè LS

Microorganisms 2020 Feb 29;8(3):348 doi: 103390/microorganisms8030348

2020

Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy

Gurian E, Giraudi P, Rosso N, Tiribelli C, Bonazza D, Zanconati F, Giuricin M, Palmisano S, de Manzini N, Sergo V, Bonifacio A

Anal Chim Acta. 2020 May 8;1110:190-198.doi: 10.1016/j.aca.2020.02.040

2020

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR analysis of serum microRNA expression in hepatocellular carcinoma

Pratama MY, Cavalletto L, Tiribelli C, Chemello L, Pascut D

Sci Rep. 2020 Feb 21;10(1):3128. doi: 10.1038/s41598-020-59682-0

2020

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro mode

Anfuso B, Tiribelli C, Adorini L, Rosso N

Sci Rep. 2020 Feb 3;10(1):1699. doi: 10.1038/s41598-020-58562-x

2020

Fatty liver, cardiometabolic disease and mortality

Bedogni G, Gastaldelli A, Foschi FG

Curr Opin Lipidol, 2020 Feb;31(1):27-31.doi: 10.1097/MOL.0000000000000652.

2020

Is Parkinson’s disease an unique clinical entity? Rigid or tremor dominant PD: Two faces of the same coin

Caruso P, Monguzzi G, Sala A, Dal Ben M, Gazzin S

J Clin Neurosci. 2020 Apr;74:18-24. doi: 10.1016/j.jocn.2020.01.068

2020

Associations among taste perception, food neophobia and preferences in type 1 diabetes children and adolescents: A cross-sectional study

Mameli C, Cattaneo C, Lonoce L, Bedogni G, Redaelli FC, Macedoni M, Zuccotti G, Pagliarini E

Nutrients. 2019 Dec 13;11(12):3052. doi: 10.3390/nu11123052.

2019

Sex- and age-related differences in the contribution of ultrasound-measured visceral and subcutaneous abdominal fat to fatty liver index in overweight and obese Caucasian adults

Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S

Nutrients. 2019 Dec 9;11(12). pii: E3008. doi: 10.3390/nu11123008

2019

Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?

Bellarosa C, Vitek L, Tiribelli C

Clin Pharmacol Ther. Dec 27. doi: 10.1002/cpt.1341

2018

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. Jun;67(6):2072-2073. doi: 10.1002/hep.29753.

2018

A new stage in Annals of Hepatology

Panduro A, Tiribelli C, Chávez-Tapia NC, Uribe M

Ann Hepatol. 17(3):339-340. doi: 10.5604/01.3001.0011.7377.

2018

Where do we stand in the field of neonatal jaundice? Commentary on the 2017 J. Donald Osrow Trieste Yellow Retreat

Riordan S, Gazzin S

Pediatr Res. Jun;83(6):1090-1092. doi: 10.1038/pr.2018.53.

2018

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.

2017

Treatments for non-alcoholic steatohepatitis - still a long way to go

 Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)

2017